Sana Biotechnology Inc. (NASDAQ:SANA) saw an upside of 1.12% to close Friday at $5.44 after adding $0.06 on the day. The 5-day average trading volume is 755,640 shares of the company’s common stock. It has gained $5.64 in the past week and touched a new high 2 times within the past 5 days. An average of 801,225 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,070,994.
SANA’s 1-month performance is -7.17% or -$0.56 on its low of $4.99 reached on 08/14/23. The company’s shares have touched a 52-week low of $2.99 and high of $8.08, with the stock’s rally to the 52-week high happening on 05/23/23. YTD, SANA has achieved 37.72% or $1.49 and has reached a new high 17 times. However, the current price is down -32.67% from the 52-week high price.
Insider Transactions
SANA stock investors last saw insider trading activity on Jun 07.Flagship Ventures Fund V Gener (10% Owner) most recently sold 200,000 shares at $6.24 per share on Jun 07. This transaction cost the insider $1,247,940. 10% Owner, Flagship Ventures Fund V Gener, sold 203,758 shares at a price of $6.31 on Jun 06. Then, on May 26, 10% Owner Flagship Ventures Fund V Gener sold 82,000 shares at a price of $6.23 per share. This transaction amounted to $510,573.
Valuation Metrics
SANA stock has a beta of 0.70. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 2.96.
Sana Biotechnology Inc.’s quick ratio for the period ended June 29 was 3.00, with the current ratio over the same period at 3.00. The firm’s gross profit as reported stood at $3.09 million against revenue of $272.56 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income grew 72.41% to -$114.0 million, while revenue of -$82.12 million was 27.96% off the previous quarter. Analysts expected SANA to announce -$0.43 per share in earnings in its latest quarter, but it posted -$0.59, representing a -37.20% surprise. SANA stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 352.12 million, with total debt at $113.14 million. Shareholders hold equity totaling $196.94 million.
Let’s look briefly at Sana Biotechnology Inc. (SANA) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 43.90% to suggest the stock is trending Neutral, with historical volatility in this time period at 41.75%.
The stock’s 5-day moving average is $5.40, reflecting a -0.37% or -$0.02 change from its current price. SANA is currently trading -11.11% above its 20-day SMA, +62.87% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -12.40% and SMA200 by-6.21%.
Stochastic %K and %D was 45.82% and 40.67% and the average true range (ATR) pointed at 0.31. The RSI (14) points at 43.48%, while the 14-day stochastic is at 55.97% with the period’s ATR at 0.32. The stock’s 9-day MACD Oscillator is pointing at -0.05 and -0.05 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Sana Biotechnology Inc. (NASDAQ: SANA), TD Cowen launched coverage with a Market perform rating. Analysts offering their rating for SANA stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate SANA as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is SANA’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $6.00 and a high of $11.00, with their median price target at $6.00. Looking at these predictions, the average price target given by analysts is for Sana Biotechnology Inc. (SANA) stock is $7.67.
